Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

CogState Ltd

CGS.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Biotechnology & Medical Research ·

Australia Small Cap Analyst: BUY

Last Close

$1.98

▲ +2.19%

Market Cap $335.61M · Vol 1.29M

Key Metrics

P/E Ratio

32.11

FWD: 21.16

Market Cap

$335.61M

Small Cap

Div Yield

1.02%

Annual dividend

EPS Growth

+18.40%

YoY

RSI (14)

73.53

Momentum

Beta

0.44

vs Market

52W High

$2.13

4.76% below

52W Low

$1.17

87.20% above

Volume

1.29M

Avg 339.07K

P/B

4.05

Price-to-book

ROE

24.89%

Return on equity

Free Float

54.70%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, CogState Ltd (CGS.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CGS.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+8.11%

+0.72%

+11.55%

+29.03%

YTD

+23.89%

+69.18%

+115.58%

+64.22%

Financials & Valuation

TTM · Annual

Total Revenue	$53.09M
Net Income	$10.14M
Revenue Growth (YoY)	+12.43%
Gross Margin	54.70%
Operating Margin	24.63%
Net Profit Margin	19.11%
ROE	24.89%
ROA · ROIC	22.69% · 22.68%

P/E Ratio	32.11
Forward P/E (FY1)	21.16
PEG Ratio	0.23
P/S	3.76
P/B	4.05
P/FCF	21.64
EPS Growth	+18.40%
Outstanding Shares	169.92M

Technical Indicators

50-Day SMA	$1.91
200-Day SMA	$1.73
RSI (14)	73.53
Beta	0.44
52-Week High	$2.13
52-Week Low	$1.17

Volume Today	1.29M
Avg Daily Volume (30D)	339.07K
Relative Volume	3.81x
Volatility (10D)	25.11
Volatility (30D)	41.52
Free Float	54.70%

Analyst Consensus

BUY

Current Price $1.98

Mean Target $2.45

52W Low$1.17 52W High$2.13

Current

Target

$1.17 $2.13

Current Analyst target

+23.70% upside potential · 3 analysts

Identifiers

ExchangeASX

FIGIBBG001SHK462

ISINAU000000CGS8

CountryAustralia

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateAug 18, 2026

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.